Pre-exposure Prophylaxis for HIV (PrEP) is taking a medicine (currently a tablet that contains drugs called Tenofovir Disoproxil and Emtricitabine) that reduces the risk of HIV infection.
Currently, PrEP is not available on the NHS.
You can access PrEP by:
Buying it online:
You can find out how at the HIV treatment information and advocacy website i-base i-base.info/guides/prep/buying-prep-online
The PrEP Impact trial:
The PrEP impact study is now open for men and transmen who have sex with men (MSM) on the PrEP Impact study. We have spaces for women and other non-MSM people who want PrEP. If you feel that you are eligible under this category, please visit our Burrell Street Sexual Health Clinic and see a Health Advisor who can facilitate a referral to the PrEP Impact study team
If you have seen a health advisor at our service and have already been referred to PrEP impact study, and not heard from us, please drop us an email at firstname.lastname@example.org If you haven’t had an assessment with one of our health advisors since October 2017, our research team will not be able to respond to your query.
If you are taking PrEP, it is important that you get checked up regularly (every 3 months). If you are getting your PrEP elsewhere, we provide monitoring free of charge at all 3 of our clinics. Just tick “I want to discuss PrEP or have it monitored” when you check in. Please attend for a monitoring session two weeks before beginning PrEP, and every three months thereafter.
The National AIDS Manual on obtaining PrEP in the UK:
I-base has an online UK guide outlining all information regarding PrEP: